Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia
Author(s) -
Steffen B. Wiegand,
Lisa Traeger,
Huan K. Nguyen,
Kaitlyn R. Rouillard,
Anna Fischbach,
Francesco Zadek,
Fumito Ichinose,
Mark H. Schoenfisch,
Ryan W. Carroll,
Donald B. Bloch,
Warren M. Zapol
Publication year - 2020
Publication title -
redox biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.059
H-Index - 88
ISSN - 2213-2317
DOI - 10.1016/j.redox.2020.101826
Subject(s) - antimicrobial , klebsiella pneumonia , nitric oxide , microbiology and biotechnology , pneumonia , klebsiella pneumoniae , klebsiella , biology , chemistry , medicine , pseudomonas aeruginosa , bacteria , biochemistry , escherichia coli , genetics , gene
Rationale Inhalation of nitric oxide (NO) exerts selective pulmonary vasodilation. Nitric oxide also has an antimicrobial effect on a broad spectrum of pathogenic viruses, bacteria and fungi. Objectives The aim of this study was to investigate the effect of inhaled NO on bacterial burden and disease outcome in a murine model of Klebsiella pneumonia. Methods Mice were infected with Klebsiella pneumoniae and inhaled either air alone, air mixed with constant levels of NO (at 80, 160, or 200 parts per million (ppm)) or air intermittently mixed with high dose NO (300 ppm). Forty-eight hours after airway inoculation, the number of viable bacteria in lung, spleen and blood was determined. The extent of infiltration of the lungs by inflammatory cells and the level of myeloperoxidase activity in the lungs were measured. Atomic force microscopy was used to investigate a possible mechanism by which nitric oxide exerts a bactericidal effect. Measurements and main results Compared to control animals infected with K. pneumoniae and breathed air alone, intermittent breathing of NO (300 ppm) reduced viable bacterial counts in lung and spleen tissue. Inhaled NO reduced infection-induced lung inflammation and improved overall survival of mice. NO destroyed the cell wall of K. pneumoniae and killed multiple-drug resistant K. pneumoniae in-vitro . Conclusions Intermittent administration of high dose NO may be an effective approach to the treatment of pneumonia caused by K. pneumoniae.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom